Early View - DiabetesontheNet

This site is intended for healthcare professionals only

Diabetes Digest

Early View

Filter:

Type 2 diabetes: Reframing the first stage of care

Attempts to achieve remission, or at least a substantial improvement in glycaemic control, should be the initial focus at type 2 diabetes diagnosis.

Early View

A low-carbohydrate weight-loss intervention: 8-year practice service evaluation

A low-carbohydrate intervention should be offered early in the diabetes journey, and before HbA1c rises too high, to maximise the odds of remission.

Early View

Effect of weight change on remission in people with newly diagnosed type 2 diabetes

Weight loss in the early stage of type 2 diabetes has an important effect on the prognosis.

Early View

Healthy versus unhealthy plant-based diets: How do they affect type 2 diabetes risk?

Not all plant-based diets are born equal for preventing type 2 diabetes.

Early View

Cumulative glycaemic exposure and cardiovascular risk

Greater HbA1c exposure, which reflects long-term glycaemic control, significantly increases the risk of CVD and mortality in type 2 diabetes.

Early View

Look AHEAD: Intensive lifestyle intervention less effective in those with higher HbA1c

Research is needed to help develop interventions that are effective for those with higher HbA1c.

Early View

New kids on the block: Friend or Foe?

Amid accumulating evidence of benefits with new diabetes drugs, Vinod Patel asks whether the costs can be justified.

Early View

Tirzepatide reduces the predicted risk of developing type 2 diabetes

Predicted relative risk of type 2 diabetes reduced by about half at 24 weeks and by about two-thirds at 72 weeks.

Early View

Efficacy and safety of once-weekly insulins: Meta-analysis

Once-weekly insulins offer similar or superior glycaemic control to daily insulins, albeit with some greater weight gain.

Early View

Effects of canagliflozin are consistent across BMI classes

Cardiovascular and renal outcomes are similar in people with type 2 diabetes irrespective of BMI category.

Early View

Benefits and adverse events of newer diabetes therapies according to frailty status

SGLT2 inhibitors and GLP-1 RAs superior to DPP-4 inhibitors even in people with high frailty scores.

Early View

Ideas for diabetes care: Something borrowed, something blue

How does the old wedding tradition relate to best practice in diabetes care? Vinod Patel reveals all!

Early View

Sustained increase in physical fitness improves cardiometabolic risk independently of weight change

Sustained increase in physical fitness improves cardiometabolic risk independently of weight change.

Early View

Weight change and risk of 13 obesity-related complications

Benefits on 13 obesity-related complications are dependent on both magnitude of weight change and initial BMI.

Early View

Sleep quality as well as duration is associated with type 2 diabetes risk

Self-reported sleep quality is associated with type 2 diabetes risk, while sleep duration shows a U-shaped association.

Early View

Real-world data shows benefits of newer type 2 diabetes therapies

SGLT2 inhibitors and GLP-1 RAs are most effective at preventing cardiorenal outcomes, with greater effects when combined.

Early View

Vitamin D supplementation and chance of regression from prediabetes to normal glucose regulation

Vitamin D supplementation reduces risk of progression in people with prediabetes, but adherence is important.

Early View

What is health? The importance of patient-centred outcomes

Vinod Patel considers what defines health, what matters to our patients with type 2 diabetes and how to promote this.

Early View

LATEST ARTICLES

Type 2 diabetes: Reframing the first stage of care

A low-carbohydrate weight-loss intervention: 8-year practice service evaluation

Effect of weight change on remission in people with newly diagnosed type 2 diabetes

Healthy versus unhealthy plant-based diets: How do they affect type 2 diabetes risk?

Cumulative glycaemic exposure and cardiovascular risk

Look AHEAD: Intensive lifestyle intervention less effective in those with higher HbA1c

New kids on the block: Friend or Foe?

For the latest news and articles

Sign up to all DiabetesontheNet journals

Follow us for all the latest news and updates in diabetes.

Resources

Journals

Useful information

© Copyright Omniamed Communications. All Rights Reserved
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom

;